C509T and T869C polymorphisms of transforming growth factor &bgr;1 and the risk of IgA nephropathy: a meta‐analysis

Background IgA nephropathy (IgAN) is the most common primary glomerular disease. Transforming growth factor &bgr;1 (TGF&bgr;1) plays an important role in pathogenesis of IgAN. Associations between the polymorphisms of TGF&bgr;1 gene and the risk of IgAN remained inconsistent. A meta‐analysis was conducted to investigate the association between polymorphisms in the TGF&bgr;1 gene and IgAN susceptibility. Methods Databases including Pubmed, EMBASE, ISI, et al. were searched to find relevant studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to evaluate the strength of associations. Results Ten studies involving 1770 cases and 1953 controls were included. Significant association between C509T polymorphism and IgAN risk was observed (OR 1.42, 95% CI 1.12–1.81, P=0.0004; I2=0%) in Caucasians by the overdominant model (CT vs. CC + TT), but no significant association was found (P=0.200) in Asians by the dominant model (CC + CT vs. TT). Significant association between T869C polymorphism and IgAN susceptibility was found (OR 1.21, 95% CI 1.02–1.44, P=0.030) in overall populations by the dominant model (TT + TC vs. CC). Subgroup analysis found T allele of T869C polymorphism was associated with IgAN susceptibility in Caucasians (P=0.030), but not in Asians (P=0.290). Conclusion Both heterozygotes of C509T polymorphism and T allele of T869C polymorphism in TGF&bgr;1 were associated with the risk of IgAN in Caucasians, but not in Asians.

[1]  Chun Chen,et al.  Role of adjuvant chemoradiotherapy in treatment of resectable esophageal carcinoma: a meta-analysis. , 2013, Chinese medical journal.

[2]  Sun-Hee Park,et al.  Impact of gene polymorphisms of interleukin-18, transforming growth factor-β, and vascular endothelial growth factor on development of IgA nephropathy and thin glomerular basement membrane disease , 2012, Kidney research and clinical practice.

[3]  Jonathan Barratt,et al.  An update on the pathogenesis and treatment of IgA nephropathy. , 2012, Kidney international.

[4]  D. Maixnerova,et al.  Association of advanced vasculopathy and transforming growth factor-beta1 gene expression with immunoglobulin A nephropathy progression. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  F. Lin,et al.  Genetic polymorphisms of the renin-angiotensin-aldosterone system in Chinese patients with end-stage renal disease secondary to IgA nephropathy. , 2010, Chinese medical journal.

[6]  Krzysztof Kiryluk,et al.  Genetic studies of IgA nephropathy: past, present, and future , 2010, Pediatric Nephrology.

[7]  G. Gambaro,et al.  Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients. , 2009, Journal of nephrology.

[8]  L. Padyukov,et al.  Genetic variation in the transforming growth factor-β1 gene is associated with susceptibility to IgA nephropathy , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  F. Lai,et al.  Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  Ammarin Thakkinstian,et al.  A method for meta‐analysis of molecular association studies , 2005, Statistics in medicine.

[11]  C. Ahn,et al.  Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with susceptibility to and progression of IgA nephropathy. , 2005, Clinical nephrology.

[12]  A. Piazza,et al.  Association between transforming growth factor beta1 gene polymorphisms and IgA nephropathy. , 2004, Journal of nephrology.

[13]  J. Guh,et al.  Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. , 2003, Journal of the American Society of Nephrology : JASN.

[14]  G. Jhangri,et al.  Cytokine single nucleotide polymorphisms and intrarenal gene expression in chronic allograft nephropathy in children. , 2003, Kidney international.

[15]  D. Comings,et al.  Molecular heterosis: a review. , 2000, Molecular genetics and metabolism.

[16]  P. Hasleton,et al.  Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. , 1998, Transplantation.

[17]  K. Ikeda,et al.  Association of a Polymorphism of the Transforming Growth Factor‐β1 Gene with Genetic Susceptibility to Osteoporosis in Postmenopausal Japanese Women , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[19]  C. Charasse,et al.  Epidemiology of primary glomerular diseases in a French region. Variations according to period and age. , 1994, Kidney international.

[20]  T. Yamamoto,et al.  Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. , 1994, Kidney international.

[21]  王洁,et al.  Relationship of transforming growth factor β1 gene 509C/T polymorphism with IgA nephropathy in Western Guangxi , 2011 .

[22]  Koichi Matsumoto,et al.  TGF-beta1 and CTGF mRNAs are correlated with urinary protein level in IgA nephropathy. , 2008, Journal of nephrology.

[23]  X. Chao,et al.  Relationship of TGFβ_1 -509C/T Polymorphism with IgA Nephropathy in Han Nationality of Chinese Population , 2005 .

[24]  S. Goto,et al.  Transforming growth factor-beta1 gene polymorphism modifies the histological and clinical manifestations in Japanese patients with IgA nephropathy. , 2004, Tissue antigens.

[25]  T. Spector,et al.  Genetic control of the circulating concentration of transforming growth factor type beta1. , 1999, Human molecular genetics.